Cardiovascular Safety of Janus Kinase Inhibitor Therapy in a Multi-ethnic Population
Musculoskeletal Care 2023 doi 10.1002/msc.1853 Epub ahead of print
This study by Sunmboye, et al. investigated the relationship between CV event incidence and age in a multi-ethnic population that received JAK inhibitor therapy. They concluded that JAK inhibitor therapy was generally safe in a multi-ethnic population with a large age range, but they did find a statistically significant but numerically small positive correlation between age and CV incidence